Sakboonyarat, Boonsub https://orcid.org/0000-0003-0577-0699
Poovieng, Jaturon
Jongcherdchootrakul, Kanlaya
Srisawat, Phutsapong
Hatthachote, Panadda
Mungthin, Mathirut
Rangsin, Ram
Funding for this research was provided by:
The Research Unit for Military Medicine, Phramongkutklao College of Medicine, Bangkok, Thailand
Article History
Received: 10 May 2023
Accepted: 25 July 2023
First Online: 22 August 2023
Declarations
:
: This study was funded by the Research Unit for Military Medicine, Phramongkutklao College of Medicine, Bangkok, Thailand.
: The authors have no relevant financial or non-financial interests to disclose.
: Consent for publication is not applicable.
: This study was reviewed and approved by the Institutional Review Board, Royal Thai Army Medical Department, following international guidelines including the Declaration of Helsinki, the Belmont Report, CIOMS Guidelines, and the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use–Good Clinical Practice (ICH–GCP) (approval number S067h/64 and S056h/65). Due to the use of secondary data, a waiver of documentation of informed consent was utilized. The Institutional Review Board, Royal Thai Army Medical Department, approved an informed consent waiver.
: The data that support the findings of this study are available from the Royal Thai Army Medical Department, Bangkok, Thailand but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are, however, available from the authors upon reasonable request and with permission of the Royal Thai Army Medical Department, Bangkok, Thailand (contact Boonsub Sakboonyarat via boonsub1991@pcm.ac.th).
: Conceptualization: BS, JP, KJ, PS, PH, MM, RR; methodology: BS, RR; formal analysis and investigation: BS; writing—original draft preparation: BS; writing—review and editing: BS, JP, KJ, PS, PH, MM, RR; funding acquisition: RR; resources: KJ, RR; supervision: RR.